Journal of Renal Nutrition
Volume 17, Issue 4 , Pages 243-249 , July 2007

The Effect of n-3 Fatty Acids on Heart Rate Variability in Patients Treated With Chronic Hemodialysis

  • My Svensson, MD

      Affiliations

    • Department of Nephrology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark.
    • Corresponding Author InformationAddress reprint requests to My Svensson, MD, Department of Nephrology, Aalborg Hospital, Aarhus University Hospital, Hobrovej 18-20, 9100 Aalborg, Denmark.
    • ,
  • Erik B. Schmidt, DMSc

      Affiliations

    • Department of Cardiology, Center for Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark.
    • ,
  • Kaj A. Jørgensen, DMSc

      Affiliations

    • Department of Renal Medicine C, Skejby Hospital, Aarhus University Hospital, Aarhus, Denmark.
    • ,
  • Jeppe H. Christensen, DMSc

      Affiliations

    • Department of Nephrology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark.

References 

  1. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
  2. US Renal Data System: USRDS 2004 Annual Data Report (Atlas of end-stage renal disease in the United States). Bethesda, MD: National Institutes of Health, National Institutes of Diabetes and Kidney Diseases; 2005;
  3. Herzog CA. Sudden cardiac death and acute myocardial infarction in dialysis patients: perspectives of a cardiologist. Semin Nephrol. 2005;25:363–366
  4. Heart rate variability: standards of measurement, physiological interpretation and clinical use (Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology). Circulation. 1996;93:1043–1065
  5. Kurata C, Uehara A, Sugi T, et al. Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron. 2000;84:312–319
  6. Robinson TG, Carr SJ. Cardiovascular autonomic dysfunction in uremia. Kidney Int. 2002;62:1921–1932
  7. Joles JA, Koomans HA. Causes and consequences of increased sympathetic activity in renal disease. Hypertension. 2004;43:699–706
  8. Tsuji H, Larson MG, Venditti FJ, et al. Impact of reduced heart rate variability on risk for cardiac events (The Framingham Heart Study). Circulation. 1996;94:2850–2855
  9. La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478–484
  10. Fukuta H, Hayano J, Ishihara S, et al. Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant. 2003;18:318–325
  11. Hayano J, Takahashi H, Toriyama T, et al. Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant. 1999;14:1480–1488
  12. Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation. 2003;107:2646–2652
  13. Matthan NR, Jordan H, Chung M, Lichtenstein AH, Lathrop DA, Lau J. A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models. Metabolism. 2005;54:1557–1565
  14. Xiao YF, Sigg DC, Leaf A. The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ion channels as a potential mechanism. J Membr Biol. 2005;206:141–154
  15. Dallongeville J, Yarnell J, Ducimetiere P, et al. Fish consumption is associated with lower heart rates. Circulation. 2003;108:820–825
  16. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation. 2005;112:1945–1952
  17. Christensen JH. n-3 fatty acids and the risk of sudden cardiac death (Emphasis on heart rate variability). Dan Med Bull. 2003;50:347–367
  18. Siscovick DS, Raghunathan T, King I, et al. Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr. 2000;71:208S–212S
  19. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113–1118
  20. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105:1897–1903
  21. Friedman A, Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol. 2006;182–192
  22. Svensson M, Schmidt EB, Jørgensen KA, Christensen JH. n-3 fatty acids as secondary prevention against cardiovascular events in patients treated with chronic hemodialysis: a randomised, placebo controlled intervention trial. Clin J Am Soc Nephrol. 2006;1:780–786
  23. Cashion AK, Cowan PA, Milstead EJ, Gaber AO, Hathaway DK. Heart rate variability, mortality, and exercise in patients with end-stage renal disease. Prog Transplant. 2000;10:10–16
  24. Yildiz A, Sever MS, Demirel S, et al. Improvement of uremic autonomic dysfunction after renal transplantation: a heart rate variability study. Nephron. 1998;80:57–60
  25. Christensen JH, Aaroe J, Knudsen N, et al. Heart rate variability and n-3 fatty acids in patients with chronic renal failure—a pilot study. Clin Nephrol. 1998;49:102–106
  26. Nishimura M, Hashimoto T, Kobayashi H, et al. Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemodialysis patients. Nephrol Dial Transplant. 2004;19:2532–2538
  27. Coquet I, Mousson C, Rifle G, et al. Influence of ischemia on heart-rate variability in chronic hemodialysis patients. Ren Fail. 2005;27:7–12
  28. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318:1730–1737
  29. Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure (A Bayesian meta-analysis). Ann Intern Med. 2001;134:550–560
  30. Abbott KC, Trespalacios FC, Agodoa LY, Taylor AJ, Bakris GL. Beta-blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality. Arch Intern Med. 2004;164:2465–2471
  31. Ezekowitz J, McAlister FA, Humphries KH, et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol. 2004;44:1587–1592
  32. Cice G, Ferrara L, D’Andrea A, et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol. 2003;41:1438–1444
  33. Tory K, Horvath E, Suveges Z, et al. Effect of propranolol on heart rate variability in patients with end-stage renal disease: a double-blind, placebo-controlled, randomized crossover pilot trial. Clin Nephrol. 2004;61:316–323
  34. Rubinger D, Sapoznikov D, Pollak A, Popovtzer MM, Luria MH. Heart rate variability during chronic hemodialysis and after renal transplantation: studies in patients without and with systemic amyloidosis. J Am Soc Nephrol. 1999;10:1972–1981
  35. Levy WC, Cerqueira MD, Harp GD, et al. Effect of endurance exercise training on heart rate variability at rest in healthy young and older men. Am J Cardiol. 1998;82:1236–1241
  36. Deligiannis A, Kouidi E, Tourkantonis A. Effects of physical training on heart rate variability in patients on hemodialysis. Am J Cardiol. 1999;84:197–202
  37. Christensen JH, Gustenhoff P, Korup E, et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ. 1996;312:677–678
  38. Holguin F, Tellez-Rojo MM, Lazo M, et al. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest. 2005;127:1102–1107
  39. Geelen A, Zock PL, Swenne CA, Brouwer IA, Schouten EG, Katan MB. Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects. Am Heart J. 2003;146:E4
  40. O’Keefe JH, Abuissa H, Sastre A, Steinhaus DM, Harris WS. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol. 2006;97:1127–1130
  41. Fiedler R, Mall M, Wand C, Osten B. Short-term administration of omega-3 fatty acids in hemodialysis patients with balanced lipid metabolism. J Ren Nutr. 2005;15:253–256
  42. Geelen A, Brouwer IA, Schouten EG, Maan AC, Katan MB, Zock PL. Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr. 2005;81:416–420
  43. Kannel WB, Kannel C, Paffenbarger RS, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J. 1987;113:1489–1494
  44. Wannamethee G, Shaper AG, Macfarlane PW, Walker M. Risk factors for sudden cardiac death in middle-aged British men. Circulation. 1995;91:1749–1756

 This study was supported by The Danish Heart Foundation, The Danish Kidney Foundation, the Research Foundation of the County of Northern Jutland and Pronova Biocare.

PII: S1051-2276(07)00047-7

doi: 10.1053/j.jrn.2007.02.004

Journal of Renal Nutrition
Volume 17, Issue 4 , Pages 243-249 , July 2007

Article Tools

* Image Usage & Resolution